Suppr超能文献

锂、睡眠剥夺和光疗(时间疗法)治疗耐药性双相情感障碍自杀症状的快速反应。

Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression.

机构信息

Istituto Scientifico Universitario Ospedale San Raffaele, Dipartimento di Neuroscienze Cliniche, San Raffaele Turro, Via Stamira d'Ancona 20, 20127 Milan, Italy

出版信息

J Clin Psychiatry. 2014 Feb;75(2):133-40. doi: 10.4088/JCP.13m08455.

Abstract

BACKGROUND

One third of patients with bipolar disorder attempt suicide. Depression in bipolar disorder is associated with drug resistance. The efficacy of antidepressants on suicidality has been questioned. Total sleep deprivation and light therapy prompt a rapid and stable antidepressant response in bipolar disorder.

METHOD

We studied 143 consecutively admitted inpatients (December 2006-August 2012) with a major depressive episode in the course of bipolar disorder (DSM-IV criteria). Among the 141 study completers, 23% had a positive history of attempted suicide and 83% had a positive history of drug resistance. During 1 week, patients were administered 3 consecutive total sleep deprivation cycles (each composed of a period of 36 hours awake followed by recovery sleep) combined with bright light therapy in the morning for 2 weeks. At admission, patients who had been taking lithium continued it, and those who had not been taking lithium started it. Severity of depression was rated according to the Hamilton Depression Rating Scale (HDRS) (primary outcome measure) and Beck Depression Inventory (BDI).

RESULTS

Two patients switched polarity. Among the 141 who completed the treatment, 70% achieved a 50% reduction in HDRS score in 1 week, which persisted 1 month after in 55%. The amelioration involved an immediate and persistent decrease in suicide scores soon after the first total sleep deprivation cycle (F3,411 = 42.78, P < .00001). A positive history of suicide attempts was associated with worse early life stress and with worse suicide scores at baseline, but it did not influence response. Patients with current suicidal thinking or planning responded equally well (F3,42 = 20.70, P < .000001). Remarkably, however, nonresponders achieved a benefit, with significantly decreased final scores also including suicidality ratings (F3,120 = 6.55, P = .0004). Self-ratings showed the same pattern of change. Previous history of drug resistance did not hamper response. During the following month, 78 of 99 responders continued to stay well and were discharged from the hospital on lithium therapy alone.

CONCLUSIONS

The combination of total sleep deprivation, light therapy, and lithium is able to rapidly decrease depressive suicidality and prompt antidepressant response in drug-resistant major depression in the course of bipolar disorder.

摘要

背景

三分之一的双相情感障碍患者企图自杀。双相情感障碍中的抑郁与抗药性有关。抗抑郁药对自杀的疗效一直存在争议。完全睡眠剥夺和光照疗法可在双相情感障碍中迅速、稳定地产生抗抑郁反应。

方法

我们研究了 143 名连续入院的患者(2006 年 12 月至 2012 年 8 月),这些患者在双相情感障碍发作期间出现了重度抑郁发作(DSM-IV 标准)。在 141 名完成研究的患者中,23%有自杀未遂史,83%有药物抵抗史。在 1 周内,患者接受了 3 个连续的完全睡眠剥夺周期(每个周期由 36 小时清醒期和随后的恢复睡眠组成),同时在早晨进行为期 2 周的强光治疗。入院时,正在服用锂的患者继续服用锂,未服用锂的患者开始服用锂。抑郁严重程度根据汉密尔顿抑郁量表(HDRS)(主要疗效测量指标)和贝克抑郁量表(BDI)进行评定。

结果

两名患者出现了极性转换。在 141 名完成治疗的患者中,70%在 1 周内达到了 HDRS 评分下降 50%,55%的患者在 1 个月后仍保持这一效果。这种改善涉及到自杀评分的即刻和持续下降,这一变化在第一次完全睡眠剥夺周期后立即出现(F3,411 = 42.78,P <.00001)。自杀未遂史与早期生活应激较差和基线时自杀评分较差有关,但并不影响反应。有当前自杀想法或计划的患者反应同样良好(F3,42 = 20.70,P <.000001)。然而,令人惊讶的是,无反应者也受益,最终评分也显著降低,包括自杀率评分(F3,120 = 6.55,P =.0004)。自我评分也显示出相同的变化模式。先前的药物抵抗史并没有阻碍反应。在接下来的一个月里,99 名应答者中的 78 名继续保持良好状态,并仅在锂治疗下出院。

结论

完全睡眠剥夺、光照疗法和锂联合应用能够迅速降低双相情感障碍中药物抵抗性重度抑郁的抑郁自杀性,并迅速产生抗抑郁反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验